Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Kavanaugh

Showing results (91-100 of 381) with videos related to

Pageof 39
Sort By:
The Journal of Rheumatology|May 15, 2026
GRAPPA Debate: Is Plain Radiography in Psoriatic Disease Still Necessary?Isaac T Cheng, Arthur Kavanaugh, William Tillett
The Journal of Allergy and Clinical Immunology|December 29, 2009
Immunomodulator therapy: monoclonal antibodies, fusion proteins, cytokines, and immunoglobulinsSusan J Lee, Javier Chinen, Arthur Kavanaugh
The Journal of Rheumatology|October 7, 2004
The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritisArthur Kavanaugh, Stanley Cohen, John J Cush
The Journal of Rheumatology|April 3, 2020
High Burden of Burnout on Rheumatology PractitionersVivekanand Tiwari, Arthur Kavanaugh, George Martin, et al.
Arthritis Research & Therapy|August 28, 2020
Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlatesGlenn Haugeberg, Mari Hoff, Arthur Kavanaugh, et al.
Therapeutic Advances in Respiratory Disease|March 12, 2011
The role of monoclonal antibodies in the treatment of severe asthmaLouanne M Tourangeau, Arthur Kavanaugh, Stephen I Wasserman
Arthritis & Rheumatology (Hoboken, N.J.)|March 16, 2023
Expert Perspective: Management of the Psoriatic Arthritis Patient After Failure of One Tumor Necrosis Factor InhibitorYing-Ying Leung, Arthur Kavanaugh, Christopher T Ritchlin
The Journal of Rheumatology|July 7, 2023
GRAPPA 2021 Treatment Recommendations for Psoriatic ArthritisEnrique R Soriano, Laura C Coates, Arthur Kavanaugh
Rheumatology (Oxford, England)|February 26, 2010
Is a 12-week trial sufficient to evaluate clinical responses to etanercept or MTX treatment in early RA?Arthur Kavanaugh, Edward Keystone, JingYuan Feng, et al.
The Journal of Rheumatology|November 3, 2014
Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPALaura C Coates, Arthur Kavanaugh, Christopher T Ritchlin, et al.
Pageof 39

Showing results (91-100 of 381) with videos related to

Sort By:
Pageof 39
The Journal of Rheumatology|May 15, 2026
GRAPPA Debate: Is Plain Radiography in Psoriatic Disease Still Necessary?Isaac T Cheng, Arthur Kavanaugh, William Tillett
The Journal of Allergy and Clinical Immunology|December 29, 2009
Immunomodulator therapy: monoclonal antibodies, fusion proteins, cytokines, and immunoglobulinsSusan J Lee, Javier Chinen, Arthur Kavanaugh
The Journal of Rheumatology|October 7, 2004
The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritisArthur Kavanaugh, Stanley Cohen, John J Cush
The Journal of Rheumatology|April 3, 2020
High Burden of Burnout on Rheumatology PractitionersVivekanand Tiwari, Arthur Kavanaugh, George Martin, et al.
Arthritis Research & Therapy|August 28, 2020
Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlatesGlenn Haugeberg, Mari Hoff, Arthur Kavanaugh, et al.
Therapeutic Advances in Respiratory Disease|March 12, 2011
The role of monoclonal antibodies in the treatment of severe asthmaLouanne M Tourangeau, Arthur Kavanaugh, Stephen I Wasserman
Arthritis & Rheumatology (Hoboken, N.J.)|March 16, 2023
Expert Perspective: Management of the Psoriatic Arthritis Patient After Failure of One Tumor Necrosis Factor InhibitorYing-Ying Leung, Arthur Kavanaugh, Christopher T Ritchlin
The Journal of Rheumatology|July 7, 2023
GRAPPA 2021 Treatment Recommendations for Psoriatic ArthritisEnrique R Soriano, Laura C Coates, Arthur Kavanaugh
Rheumatology (Oxford, England)|February 26, 2010
Is a 12-week trial sufficient to evaluate clinical responses to etanercept or MTX treatment in early RA?Arthur Kavanaugh, Edward Keystone, JingYuan Feng, et al.
The Journal of Rheumatology|November 3, 2014
Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPALaura C Coates, Arthur Kavanaugh, Christopher T Ritchlin, et al.
Pageof 39